Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) flare
Vasculitis · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An ANCA-associated small-vessel vasculitis in patients with asthma and eosinophilia, presenting acutely with vasculitic organ involvement - mononeuritis multiplex, cardiac, renal, GI or alveolar haemorrhage - alongside a severe asthma/eosinophilia flare.
Red flags
- Cardiac involvement (myocarditis/heart failure - leading cause of death)
- Alveolar haemorrhage
- Rapidly progressive glomerulonephritis
- Mononeuritis multiplex / severe neuropathy
Assessment
Differential diagnosis
- Severe asthma exacerbation
- Hypereosinophilic syndrome
- Other ANCA vasculitis (GPA, MPA)
- Eosinophilic pneumonia
- Parasitic infection
Investigations
- FBC (marked eosinophilia)
- ANCA (often positive)
- U&E and urinalysis (renal involvement)
- Troponin/ECG/echo (cardiac involvement - a major cause of death)
- CXR/CT chest; nerve conduction if neuropathy
- CRP/ESR
Management
- Assess and support organ function; treat any life-threatening manifestation (alveolar haemorrhage, cardiac, severe asthma)
- Give high-dose corticosteroids promptly
- Add further immunosuppression (e.g. cyclophosphamide) for severe organ- or life-threatening disease on specialist advice
- Manage severe asthma component
- Involve rheumatology/immunology and relevant organ specialties urgently
- Monitor for treatment complications
Drugs & doses
High-dose corticosteroids (IV methylprednisolone for severe disease)
Cyclophosphamide (or rituximab) for organ/life-threatening involvement per specialist
Supportive organ therapy
Asthma treatment as needed
Disposition
Admit; ICU for organ-threatening disease; rheumatology/immunology and organ specialty involvement.
Complications & pitfalls
- Cardiomyopathy / heart failure
- Renal failure
- Alveolar haemorrhage
- Permanent neurological deficit
Exam pearls
- Cardiac involvement drives mortality - check troponin and cardiac function early
- Consider it in an asthmatic with new eosinophilia and multi-organ symptoms
- Leukotriene receptor antagonist use has been associated with unmasking the disease when steroids are reduced
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.